(Q39043758)

8 September 2017

Visceral leishmaniasis (Kala-azar) in two patients with HIV-1 infection: atypical features and response to therapy (English)

1 reference

8 September 2017

visceral leishmaniasis

1 reference

Hamour AA

1

1 reference

8 September 2017

Skelly R

2

1 reference

8 September 2017

Jowitt SN

3

1 reference

8 September 2017

Wilson GE

4

1 reference

8 September 2017

Curry A

5

1 reference

8 September 2017

Wilkins EG

6

1 reference

8 September 2017

Mandal BK

7

1 reference

8 September 2017

1 March 1998

1 reference

8 September 2017

1 reference

8 September 2017

36

1 reference

8 September 2017

2

1 reference

8 September 2017

217-220

1 reference

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Asymptomatic leishmaniasis in the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Short communication Visceral leishmaniasis (kala azar) in a patient with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Visceral leishmaniasis: more prevalent and more problematic

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Relapse of visceral leishmaniasis in patients who were coinfected with human immunodeficiency virus and who received treatment with liposomal amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Interferon-gamma associated with conventional therapy for recurrent visceral leishmaniasis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2898%2980017-0

7 January 2021

10.1016/S0163-4453(98)80017-0

Identifiers

DOI

1 reference

8 September 2017

1 reference